Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane.
暂无分享,去创建一个
[1] A J Moskowitz,et al. Bayesian estimation of cost-effectiveness ratios from clinical trials. , 1999, Health economics.
[2] Hans Keiding,et al. Cost-effectiveness with multiple outcomes. , 2004, Health economics.
[3] M. Sculpher,et al. Representing uncertainty: the role of cost-effectiveness acceptability curves. , 2001, Health economics.
[4] M J Al,et al. A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty. , 2000, Health economics.
[5] S. Gabriel,et al. The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] A O'Hagan,et al. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies , 2002, Statistical methods in medical research.
[7] Larry D Lynd,et al. Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis. , 2004, Journal of clinical epidemiology.
[8] J. Breman,et al. Treatment of Chioroquine-Resistant Malaria in African Children: A Cost-Effectiveness Analysis , 1992 .
[9] Andrea Manca,et al. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. , 2004, Health economics.
[10] A O'Hagan,et al. Bayesian cost‐effectiveness analysis from clinical trial data , 2001, Statistics in medicine.
[11] J O Chinnis,et al. BAYESIAN COST-EFFECTIVENESS ANALYSIS , 2001, International Journal of Technology Assessment in Health Care.
[12] W Ray Kim,et al. Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation. , 2002, Health economics.
[13] A O'Hagan,et al. A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.
[14] A A Stinnett,et al. Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[15] D. Heitjan,et al. Bayesian interim analysis of phase II cancer clinical trials. , 1997, Statistics in medicine.
[16] Anthony O'Hagan,et al. Case study in the Bayesian analysis of a cost‐effectiveness trial in the evaluation of health care technologies: Depression , 2003 .
[17] A H Briggs,et al. A Bayesian approach to stochastic cost-effectiveness analysis. , 1999, Health economics.
[18] A O'Hagan,et al. Bayesian Assessment of Sample Size for Clinical Trials of Cost-Effectiveness , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[19] E. Puigdollers,et al. Programas de mantenimiento de metadona con servicios auxiliares: un estudio de coste-efectividad , 2003 .
[20] David J. Spiegelhalter,et al. Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.